(Q44530237)

3 December 2017

title

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels (English)

1 reference

3 December 2017

0 references

0 references

0 references

Dick F Swaab

5

0 references

author name string

Jiang-Ning Zhou

1

1 reference

3 December 2017

Rong-Yu Liu

2

1 reference

3 December 2017

Wouter Kamphorst

3

1 reference

3 December 2017

Michel A Hofman

4

1 reference

3 December 2017

publication date

1 September 2003

1 reference

Journal of Pineal Research

3 December 2017

published in

1 reference

3 December 2017

volume

35

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

125-130

1 reference

Entrainment of rat circadian rhythms by daily injection of melatonin depends upon the hypothalamic suprachiasmatic nuclei.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Loss of intraventricular fluid melatonin can explain the neuropathology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Protective effect of melatonin in a chronic experimental model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Electron transport chain defects in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

On pineal calcification and its relation to subjective sleep perception: a hypothesis-driven pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

Alterations in the circadian rhythm of salivary melatonin begin during middle-age

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

A review of the evidence supporting melatonin's role as an antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Decreased Melatonin Levels in Postmortem Cerebrospinal Fluid in Relation to Aging, Alzheimer's Disease, and Apolipoprotein E- 4/4 Genotype

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Melatonin as a free radical scavenger: implications for aging and age-related diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Circadian and daily rhythms of melatonin in the blood and pineal gland of free-running and entrained Syrian hamsters

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Protein oxidation and aging

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Melatonin in relation to cellular antioxidative defense mechanisms.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Melatonin prevents beta-amyloid-induced lipid peroxidation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

The amyloid beta protein induces oxidative damage of mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

The human pineal gland in aging and Alzheimer's disease: patterns of cytoskeletal antigen immunoreactivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Cerebrospinal fluid production is reduced in healthy aging

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Increased Cortisol Levels in Aging and Alzheimer's Disease in Postmortem Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

Monozygotic twins with Alzheimer's disease treated with melatonin: Case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00065.X

7 January 2021

10.1034/J.1600-079X.2003.00065.X

Identifiers

DOI

1 reference

3 December 2017

1 reference